Myrtelle Canavan
Myrtelle Canavan (June 24, 1879 – August 4, 1953) was an American physician and pathologist known for her contributions to the field of neuropathology. She is best known for her discovery of Canavan disease, a rare genetic disorder that affects the central nervous system.
Early Life and Education[edit | edit source]
Myrtelle Canavan was born in Greenfield, Massachusetts. She attended Smith College, where she earned her undergraduate degree in 1900. She then went on to study at the Boston University School of Medicine, receiving her medical degree in 1905.
Career[edit | edit source]
After completing her medical education, Canavan worked at several institutions, including the Massachusetts State Hospital and the Boston Psychopathic Hospital. She became a prominent figure in the field of neuropathology, focusing on the study of brain diseases.
[edit | edit source]
In 1931, Canavan described a new form of leukodystrophy, which later became known as Canavan disease. This disorder is characterized by the degeneration of the white matter in the brain, leading to severe neurological impairment. Her work laid the foundation for further research into the genetic and biochemical aspects of the disease.
Contributions to Neuropathology[edit | edit source]
Canavan's research extended beyond Canavan disease. She made significant contributions to the understanding of various neurological disorders, including multiple sclerosis and Alzheimer's disease. Her work helped to advance the field of neuropathology and improve diagnostic techniques.
Legacy[edit | edit source]
Myrtelle Canavan's pioneering work in neuropathology has had a lasting impact on the field. Her discovery of Canavan disease has led to increased awareness and research into genetic disorders affecting the nervous system. She is remembered as a trailblazer for women in medicine and a dedicated scientist.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD